diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis

Authors

mohammadhassan jokar

mahmood mahmoodi

sara hesari

mansooreh sobhani

abstract

objective: anti-cyclic citrullinated peptide (anti-ccp) antibodies are highly specific markers for rheumatoid arthritis (ra) and useful for predicting rheumatoid arthritis (ra) development and progression. we assessed the diagnostic value of anti-ccp antibodies in our patients with ra. materials and methods: anti-ccp antibodies and rheumatoid factor (rf) titers were determined in 247 serum samples: 128 from ra patients, 119 from control group (48 from healthy controls, 71 from patients with rheumatic disease other than ra or hematologic malignancies). results: there were 128 (93 females, 35 males) patients with rheumatoid arthritis and 119 (78 females, 41 males) controls. the sensitivity of anti-ccp was 66.40% for diagnosis of ra with a specificity of 94.11%. the sensitivity of rf was 69.53% and its specificity was 81.51%. conclusion: in our patients anti-ccp has a moderate sensitivity but high specificity for diagnosis of ra.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.

Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. The aim of this study was to evaluate the diagnostic value of anti CCP antibodies in patients with RA. This study included three groups; group I: 60 early diagnosed RA patients selected according to the ACR, group II: 30 patients of arthritis other than RA, group III: 10 healthy age and sex matche...

full text

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

BACKGROUND Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been of diagnostic value in Northern European Caucasian patients with rheumatoid arthritis (RA). In these populations, anti-CCP antibodies are associated with the HLA-DRB1 shared epitope. We assessed the diagnostic value of anti-CCP antibodies in Greek patients with RA where the HLA shared epitope was reported in a minority...

full text

[Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis].

There is strong evidence that the determination of autoantibodies against filaggrine is a very useful tool for the diagnosis of rheumatoid arthritis (RA). Anti-cyclic citrullinated peptide antibodies (Anti-CCP)-ELISA appear to be the most efficient test among those available for the detection of antifilaggrine autoantibodies, as it has the best diagnostic accuracy for the diagnosis of RA. Furth...

full text

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

OBJECTIVE To assess the additional diagnostic and clinical value of the second test generation of anti-cyclic citrullinated peptide antibodies (CCP2) compared with rheumatoid factor isotypes (IgG-RF, IgA-RF, IgM-RF) in patients with rheumatoid arthritis. METHODS This was a prospective study on 715 patients: rheumatoid arthritis (n = 295), degenerative or other inflammatory joint disease (n = ...

full text

Diagnostic value of third generation anti-cyclic citrullinated peptide assay in rheumatoid factor negative rheumatoid arthritis

Objective: This study aimed to evaluate the diagnostic usefulness of second and third generation anticyclic citrullinated peptide (anti-CCP2 and anti-CCP3) assays in Chinese patients with rheumatoid arthritis (RA), and to identify the potential advantages of anti-CCP3 diagnosis in rheumatoid factor (RF) negative RA patients. Methods: Serum samples were obtained from 148 RA patients and 120 cont...

full text

My Resources

Save resource for easier access later


Journal title:
modares journal of medical sciences: pathobiology

Publisher: tarbiat modares university

ISSN 1562-9554

volume 10

issue Autumn & Winner2008 2010

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023